Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
How It Works (Step-by-Step) Take an online quiz to check eligibility Join and complete initial onboarding Get labs done and meet your coach Meet your clinician and start your plan Insurance team secures GLP-1 access Begin medication and curriculum Final labs and progress review at 12 months Geographic Availability Available in all 50 states Clinical Oversight and Safety US-licensed and board-certified clinicians oversee all care Lab work required early in the program and again at the end of the year Dose adjustments based on individual progress, insurance approval, and safety needs Communication with both clinicians and coaches via app Initial coaching begins within 1 week
Elevations in levels of amylase, lipase and amylase+lipase grade III have been reported in 8%, 27% and 10% of the cases respectively, in a retrospective analysis covering 119 patients treated by nivolumab and/or ipilimumab
Lipids 1862 , 11461154 (2017)
It is possible that studies with negative or non-significant results were less likely to be published, which could lead to an overestimation of treatment effects
This product is not intended to diagnose, treat, prevent or cure any disease
